Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19
Author:
Simona Tripon,Pascal Bilbault,Thibaut Fabacher,Nicolas Lefebvre,Sylvain Lescuyer,Emmanuel Andres,Elise Schmitt,Sabrina Garnier-KepKA,Pierrick Le Borgne,Joris Muller,Hamid Merdji,Frédéric Chaffraix,Didier Mutter,Thomas F Baumert,Ferhat Meziani et al.
Publication:
Clinics and Research in Hepatology and Gastroenterology
© 2022 Elsevier Masson SAS. All rights reserved.